Phathom Pharmaceuticals, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $175.1 | $55.3 | $0.7 | $0.0 | — |
| Operating income | -$160.0 | -$277.5 | -$167.3 | -$172.4 | -$135.1 |
| Net income | -$221.2 | -$334.3 | -$201.6 | -$197.7 | -$143.9 |
| Balance Sheet | |||||
| Total debt | $200.0 | $200.0 | $140.0 | $100.0 | $100.0 |
| Cash Flow Statement | |||||
| Free cash flow | -$167.0 | -$266.9 | -$139.2 | -$147.6 | -$148.8 |
Shares outstanding 80.9M · Free float 60.0%
Annual filing data through FY ended December 31, 2025; float as of October 4, 2026.